CBS 2019
CBSMD教育中心
中 文

急性冠脉综合征

Abstract

Recommended Article

Percutaneous Support Devices for Percutaneous Coronary Intervention Canadian spontaneous coronary artery dissection cohort study: in-hospital and 30-day outcomes Switching P2Y12-receptor inhibitors in patients with coronary artery disease Current Smoking and Prognosis After Acute ST-Segment Elevation Myocardial Infarction: New Pathophysiological Insights Canadian Multicenter Chronic Total Occlusion Registry: Ten-Year Follow-Up Results of Chronic Total Occlusion Revascularization Healed Culprit Plaques in Patients With Acute Coronary Syndromes An open-Label, 2 × 2 factorial, randomized controlled trial to evaluate the safety of apixaban vs. vitamin K antagonist and aspirin vs. placebo in patients with atrial fibrillation and acute coronary syndrome and/or percutaneous coronary intervention: Rationale and design of the AUGUSTUS trial Interval From Initiation of Prasugrel to Coronary Angiography in Patients With Non–ST-Segment Elevation Myocardial Infarction

Clinical Trial2021 Apr 10;28(2):227-234.

JOURNAL:Eur J Prev Cardiol. Article Link

No causal effects of plasma homocysteine levels on the risk of coronary heart disease or acute myocardial infarction: A Mendelian randomization study

L Miao, GX Deng, RX Yin et al. Keywords: plasma homocysteine levels; CHD; AMI; mendelian randomization study

Full Text PDF